Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: NPM-ALK modulates the p53 tumour suppressor pathway in a JNK and PI 3-Kinase dependent manner: MDM-2 is a potential therapeutic target for the treatment of ALK-expressing malignancies, European Journal of Cancer Supplements, July 2008, Elsevier,
DOI: 10.1016/s1359-6349(08)71315-6.
You can read the full text:
Contributors
The following have contributed to this page
